New Delhi, March 4 (IANS) India’s global chemical sector share is set to increase to 5-6 per cent by 2030 and achieve a $1 trillion turnover by 2040, according to the government.According to Union Minister JP Nadda, the budgetary provision of Rs 13,000 crore for Bio-Pharma SHAKTI and three dedicated Chemical Parks in the country is a strategic bet on India’s future.Addressing a post-Budget webinar, the minister said that 40 per cent of medicines globally will be biologics by 2035. About $300…
Latest Central Drugs Standard Control Organization News & Updates
Washington, Feb 2 (IANS) The annual Union Budget sends a clear policy signal on biopharma and healthcare innovation, the USA India Chambers of Commerce (USAIC) said, citing new investments, expansion of clinical trial infrastructure, and steps toward global regulatory alignment.The government’s early focus on biopharma, including the Biopharma Shakti initiative and the plan to create 1,000 clinical trial sites nationwide, reflected a decisive push to move India up the global value chain in bio…
New Delhi, Jan 28 (IANS) Union Ministry of Health and Family Welfare on Tuesday notified key amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019, which will help reduce drug development timelines, as well as strengthen the clinical research and pharmaceutical development ecosystem.The amendments are aimed at simplifying regulatory processes, reducing approval timelines, and promoting ease of doing business.The regulatory reforms will provide substantial benefits to stakeholders wh…